Skip to Content
🌐Ship toSelect country

Pluryal Densify - 1 x 2ml

Pluryal Densify is a polynucleotide-based skin 'densifier' from MD Skin Solutions' HPN (Highly Purified Polynucleotide) technology range, designed to hydrate deep within the skin, boost collagen production and support the skin's own fibroblast and stem-cell repair activity across the whole face. It functions as both a skin healer and scalp-repairing treatment, improving overall skin texture, firmness and radiance. For use by licensed, trained medical professionals only.

90.00 € 90.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Skin Boosters Brand Pluryal
SKU A3521 Share
Treatment Areas CheeksChinFace
Tags Cross-Linked Hyaluronic AcidHyaluronic AcidVolumizer

Pluryal Densify is a high-viscosity, cross-linked hyaluronic acid filler from the Pluryal range, formulated for facial volumising in areas such as the cheeks and chin. Pluryal is manufactured by MD Skin Solutions and distributed across the professional aesthetics market as a cross-linked hyaluronic acid range spanning facial fillers, mesotherapy cocktails and skin boosters. Its dense, cohesive gel is designed to provide strong lifting support for a natural-looking result.

CONCENTRATION

  • Cross-linked hyaluronic acid (high density)

THE PACK INCLUDES

  • 1 x 2ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Protect from direct sunlight

RESULTS & DURATION

Results typically last 12-15 months.

INDICATIONS

  • Loss of cheek and mid-face volume
  • Chin volumising

TREATMENT AREAS

  • Cheeks
  • Chin
  • Face, general

Pluryal Densify is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin